Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-11-22FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original application for rosuvastatin calcium (generic rosuvastatin calcium) from Quallent Pharmaceuticals Health LLC. The …
-
FDA approval · 2017-11-21FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's original application for a generic fixed-dose combination of ezetimibe and simvastatin (EZETIMIBE AND SIMVASTATIN). Th…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes [NA]
Completed clinical trial ESTEEM evaluating the effect of a simple, targeted diet in pregnant women with metabolic risk factors on pregnancy …
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol. [NA]
A completed clinical trial evaluated whether daily intake of citron peel extract affects blood cholesterol in individuals with hyperlipidemi…
-
FDA approval · 2017-11-16FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)
FDA approved fenofibrate from Bostal LLC through an original application (ANDA 207805).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: SOS Nutrition Project
The SOS Nutrition Project, sponsored by the University of North Carolina, Charlotte, has completed its clinical trial studying effects on hy…
-
FDA approval · 2017-10-30FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories, en…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Differential Metabolism of Dietary Fatty Acids [NA]
Completed clinical trial from the National Institute of Diabetes and Digestive and Kidney Diseases evaluating differential metabolism of die…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease
A completed clinical trial evaluating magnetic resonance angiography to diagnose atherosclerotic disease.
-
FDA approval · 2017-10-02FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc.
-
FDA approval · 2017-09-18FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental ANDA for Gemfibrozil from NorthStar Rx LLC, confirming regulatory approval of a generic Gemfibrozil product.
-
FDA approval · 2017-09-11FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc., signaling an approved modification to the existing…
-
FDA approval · 2017-09-11FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)
The FDA approved a supplemental application for Gemfibrozil filed by Cadila Pharmaceuticals Limited.
-
FDA approval · 2017-09-07FDA Approved: FENOFIBRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for fenofibrate (generic fenofibrate).
-
FDA approval · 2017-08-25FDA Approved: EZETIMIBE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for ezetimibe from Aurobindo Pharma Limited, enabling a generic version of the cholesterol-lowering dr…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Safety for 24 Weeks Intake of Korean Red Ginseng in Adults [NA]
This update reports safety findings from a 24-week intake of Korean Red Ginseng in adults, including healthy individuals and those with diab…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of a fixed-dose combination of fimasartan, amlodipine, and rosuvastatin (NCT0299572…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: CKD-337 Drug Interaction Study [Phase 1]
CKD-337 underwent a Phase 1 drug interaction study sponsored by Chong Kun Dang Pharmaceutical; the trial in participants with hyperlipidemia…
-
FDA label_change · 2017-08-04FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA is reviewing a supplemental application for LESCOL XL (fluvastatin sodium) from Sandoz Inc., likely involving changes to the product lab…
-
FDA approval · 2017-08-04FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for Lovastatin (generic statin). The approval pertains to changes under the AND…
-
FDA label_change · 2017-07-27FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PRALUENT (alirocumab) from Regeneron Pharmaceuticals to update the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events [Phase 3]
A Phase 3 randomized trial of bococizumab in adults with hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events has completed…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events [Phase 3]
Phase 3 randomized trial of bococizumab in people with primary hyperlipidemia or mixed dyslipidemia at risk for cardiovascular events comple…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 [Phase 1]
This phase 1 pharmacokinetic study assesses potential drug-drug interaction between CKD-330 and D086.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: An Analysis of Diabetes Control in Puerto Rico
This document summarizes results from a completed clinical trial evaluating diabetes control in Puerto Rico, with participants who also had …